Drug companies greet 2019 with U.S. price hikes By Reuters


© Reuters. FILE PHOTO: The Allergan logo is seen in this photo illustration By Michael Erman NEW YORK (Reuters) – Drugmakers kicked off 2019 with price increases in the United States on more than 250 prescription drugs, including the world’s top-selling medicine, Humira, although the pace of price hikes wasRead More →